Genor Biopharma Statements
69
Genor Biopharma Income Statement
B
M
CNY (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
—
100
—
0
—
0
224.78
0
72.643
0
295.78
0
-295.78
0
19.624
0
—
0
-276.16
0
-1.117
0
-274.55
0
-0.543
505.75
12.976
100
0.196
1.5
12.78
98.5
288.74
2225.2
70.161
540.7
360
2774.4
-347.22
-2675.9
24.052
185.4
—
0
-323.17
-2490.5
0.61
4.7
-324.58
-2501.4
-0.637
509.37
2.956
100
0.787
26.6
2.169
73.4
295.14
9984.4
147.11
4976.7
437.67
14806.1
-435.5
-14732.7
26.247
887.9
—
0
-409.25
-13844.8
-2.634
-89.1
-405.63
-13722.3
-0.813
499.23
—
100
—
0
—
0
341.19
0
161.42
0
464.76
0
-464.76
0
5.088
0
—
0
-459.81
0
3.018
0
-464.33
0
-0.931
498.97
—
100
—
0
—
0
271.53
0
144.53
0
410.65
0
-410.65
0
4.223
0
—
0
-406.49
0
-3.95
0
-400.89
0
-0.816
491.39
10.331
100
2.596
25.1
7.735
74.9
660.35
6391.9
239.49
2318.2
2 910.21
28169.6
-2 902.47
-28094.8
-133.17
-1289.01
-0.12
-1.2
-3 036.31
-29390.3
-5.806
-56.2
-3 027.1
-29301.2
-12.361
244.89
3.757
100
0.837
22.3
2.92
77.7
236.35
6291.1
60.872
1620.2
388.96
10352.9
-386.04
-10275.2
-7.671
-204.2
—
0
-393.72
-10479.6
-1.649
-43.9
-391.42
-10418.4
-1.084
361.21
—
100
—
0
—
0
103.03
0
32.373
0
142.76
0
-142.76
0
-0.744
0
-0.025
0
-143.56
0
-1.039
0
-141.97
0
-0.393
361.21
13.039
100
9.562
73.3
3.477
26.7
408.28
3131.2
88.479
678.6
523.98
4018.5
-520.5
-3991.9
-3.002
-23.02
-0.063
-0.5
-523.64
-4015.9
-0.891
-6.8
-522.08
-4004.003
-1.445
361.21
1.315
100
0.919
69.9
0.396
30.1
63.222
4807.8
5.557
422.6
74.443
5661.1
-74.047
-5631
-0.25
-19.01
—
0
-74.317
-5651.5
—
0
-74.317
-5651.5
-0.206
361.21